Cue Biopharma, Inc. (CUE) vs Oramed Pharmaceuticals Inc. (ORMP)

A side-by-side comparison of Cue Biopharma, Inc. and Oramed Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CUE vs ORMP

growth of $100 · dividends reinvested · last 9y
CUE -93.0% (-25.6%/yr)ORMP -46.7% (-6.7%/yr)ORMP compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020182020202220242026$7$53
CUE ORMP

CUE vs ORMP: by the numbers

  • •ORMP is the larger company ($179M vs $168M market cap).
  • •ORMP is profitable (3202.50% net margin) while CUE runs a net loss (-435.83%).
  • •ORMP pays a dividend (5.59% yield), while CUE has no payments in the available dividend history.

Metrics side by side

Valuation

MetricCUEORMP
P/E ratioN/A1.07
P/S ratio4.46N/A
P/B ratio72.770.56

Profitability

MetricCUEORMP
Gross margin99.69%0.65%
Operating margin-96.56%-754.40%
Net margin-435.83%3202.50%
ROE-7104.24%55.08%
ROIC-1039.56%-3.21%

Dividends

MetricCUEORMP
Dividend yieldN/A5.59%
Payout ratioN/A6.08%

Growth (annualized)

MetricCUEORMP
Revenue CAGR (5Y)47.08%N/A
Total return CAGR (5Y)-42.42%-25.80%

Frequently asked

Does CUE or ORMP pay a bigger dividend?
ORMP pays a dividend (5.59% yield), while CUE has no payments in the available dividend history.
Is CUE or ORMP more profitable?
ORMP runs the higher net margin — CUE at -435.83% versus ORMP at 3202.50%.
How have CUE and ORMP total returns compared?
Over the past 5 years, CUE delivered -42.42% and ORMP delivered -25.80% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.